Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Bell

Showing results (101-110 of 199) with videos related to

Pageof 20
Sort By:
Molecular Therapy Oncolytics|April 28, 2016
Evidence for differential viral oncolytic efficacy in an in vitro model of epithelial ovarian cancer metastasisJessica G Tong, Yudith Ramos Valdes, John W Barrett, et al.
Plos One|January 13, 2010
Intravenously administered alphavirus vector VA7 eradicates orthotopic human glioma xenografts in nude miceJari E Heikkilä, Markus J V Vähä-Koskela, Janne J Ruotsalainen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
A phase 1 clinical study of intravenous administration of PV701, an oncolytic virus, using two-step desensitizationScott A Laurie, John C Bell, Harold L Atkins, et al.
Molecular and Cellular Biology|October 13, 2006
Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stressJaime D Blais, Christina L Addison, Robert Edge, et al.
Molecular Therapy Oncolytics|June 18, 2021
MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancerHans Martin Singh, Mathias Felix Leber, Sascha Bossow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2008
Oncolytic efficacy of recombinant vesicular stomatitis virus and myxoma virus in experimental models of rhabdoid tumorsYushui Wu, Xueqing Lun, Hongyuan Zhou, et al.
Circulation|January 28, 2014
Double-stranded RNA-dependent protein kinase deficiency protects the heart from systolic overload-induced congestive heart failureHuan Wang, Xin Xu, John Fassett, et al.
Journal for Immunotherapy of Cancer|June 21, 2018
Enhanced susceptibility of cancer cells to oncolytic rhabdo-virotherapy by expression of Nodamura virus protein B2 as a suppressor of RNA interferenceDonald Bastin, Amelia S Aitken, Adrian Pelin, et al.
ACS Nanoscience Au|August 14, 2023
Luciferase-Based Biosensors in the Era of the COVID-19 PandemicTaha Azad, Helena J Janse van Rensburg, Jessica Morgan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 30, 2013
Leukemia cell-rhabdovirus vaccine: personalized immunotherapy for acute lymphoblastic leukemiaDavid P Conrad, Jovian Tsang, Meaghan Maclean, et al.
Pageof 20

Showing results (101-110 of 199) with videos related to

Sort By:
Pageof 20
Molecular Therapy Oncolytics|April 28, 2016
Evidence for differential viral oncolytic efficacy in an in vitro model of epithelial ovarian cancer metastasisJessica G Tong, Yudith Ramos Valdes, John W Barrett, et al.
Plos One|January 13, 2010
Intravenously administered alphavirus vector VA7 eradicates orthotopic human glioma xenografts in nude miceJari E Heikkilä, Markus J V Vähä-Koskela, Janne J Ruotsalainen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
A phase 1 clinical study of intravenous administration of PV701, an oncolytic virus, using two-step desensitizationScott A Laurie, John C Bell, Harold L Atkins, et al.
Molecular and Cellular Biology|October 13, 2006
Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stressJaime D Blais, Christina L Addison, Robert Edge, et al.
Molecular Therapy Oncolytics|June 18, 2021
MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancerHans Martin Singh, Mathias Felix Leber, Sascha Bossow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2008
Oncolytic efficacy of recombinant vesicular stomatitis virus and myxoma virus in experimental models of rhabdoid tumorsYushui Wu, Xueqing Lun, Hongyuan Zhou, et al.
Circulation|January 28, 2014
Double-stranded RNA-dependent protein kinase deficiency protects the heart from systolic overload-induced congestive heart failureHuan Wang, Xin Xu, John Fassett, et al.
Journal for Immunotherapy of Cancer|June 21, 2018
Enhanced susceptibility of cancer cells to oncolytic rhabdo-virotherapy by expression of Nodamura virus protein B2 as a suppressor of RNA interferenceDonald Bastin, Amelia S Aitken, Adrian Pelin, et al.
ACS Nanoscience Au|August 14, 2023
Luciferase-Based Biosensors in the Era of the COVID-19 PandemicTaha Azad, Helena J Janse van Rensburg, Jessica Morgan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 30, 2013
Leukemia cell-rhabdovirus vaccine: personalized immunotherapy for acute lymphoblastic leukemiaDavid P Conrad, Jovian Tsang, Meaghan Maclean, et al.
Pageof 20